Soy-diet has beneficial effects on cardiovascular parameters that are independent of its lipid effect in male hypercholesterolemic rats

Phytotherapy Research

Volumn 23, Issue 5, 2009, Pages 624-627

  Fatehi, M ^a   Farrokhfall, K ^a   Davoudi, S ^a   Collins, T M ^b   Fatehi Hassanabad, Zahra ^a,b,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Acetylcholine; Cholesterol; L NAME; Rat; Soybean

Indexed keywords

ACETYLCHOLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SOYBEAN PROTEIN; TRIACYLGLYCEROL; CARDIOVASCULAR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; HYPERCHOLESTEROLEMIA; INCUBATION TIME; MALE; NONHUMAN; RAT; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RING; ANIMAL; AORTA; BLOOD; BLOOD PRESSURE; CHOLESTEROL INTAKE; DIET THERAPY; DRUG EFFECT; METABOLISM; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALIA; GLYCINE MAX; RATTUS;

ANIMALS; AORTA; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; HYPERCHOLESTEROLEMIA; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS; TRIGLYCERIDES;

EID: 65649122989     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2673     Document Type: Article

References (27)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595.
2. Baum JA, Teng H, Erdman JW Jr, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF, Potter SM. 1998. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68: 545-551. (Pubitemid 28402375)
3. Bonetti PO, Lerman LO, and Lerman A. 2003. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Throm Vas 23: 168-175.
4. Blum AB, Lang N, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Peleg A, and Ben-Ami M. 2003. Effects of soy protein on endothelium-dependent vasodilation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clin Invest Med 26: 20-26.
5. Clarkson TB. 2002. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132: 566S-569S.
6. Cordellini S. 1999. Endothelial dysfunction in DOCA-salt hypertension, possible involvement of prostaglandin endoperoxides. Gen Pharmacol 32: 315-320.
7. Fatehi M, Anvari K, Fatehi-hassanabad Z. 2002. The beneficial effects of protein tyrosine kinase inhibiton on the circulatory failure induced by endotoxin in the rat. Shock 18: 450-455.
8. Friedwald WT, Levy IR, Friedrickson SD. 1972. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
9. Garg U, Hassid A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777.
10. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. 1995. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Throm Vas 15: 1652-1659.
11. Guerra JR. 1989. Mechanism of abnormal endothelium-dependent vacular relaxation in atherosclerosis: implication for altered autocrine and paracrine functions of EDRF. Blood Vessels 26: 300-314.
12. Henry RJUM. 1974. Clinical chemistry (2nd edn). Harper and Row Publishers: New York.
13. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz LD. 2000. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101: 1792-1798.
14. Holzer G, Esterbauer H, Kronke G, Exner M, Kopp CW, Leitinger N, Wagner O, Gmeiner BMK, Kapiotis S. 2007. The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC. Thromb Res 120: 71-79.
15. Hwang J, Wang J, Morazzoni P, Hodis HN, Sevanian A. 2003. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radical Bio Med 34: 1271-1282.
16. Ludmer P, Selwyn A, Shook TL. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New England J Med 315: 1046-1051
17. McGowan MW, Artiss JD, Standbergh DR, Zak B. 1983. Aperoxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29: 538-542.
18. Mishra SK, Abbot SE, Choudhury Z, Cheng M, Khatab N, Maycock NJ, Zavery A, and Aaronson PI. 2000. Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens and daidzein. Cardiovasc Res 46: 539-546.
19. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M. 1997. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Throm Vas 17: 3392-3398.
20. Ooboshi H, Toyoda K, Faraci FM, Lang MG, Heistad DD. 1998. Improvement of relaxation of in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler Throm Vas 18: 1752-1758.
21. Radomski MW, Rees DD, Dutra A, Moncada S. 1992. S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 107: 745-749.
22. Rathel TR, Leikert JF, Vollmar AM, Dirsch VM. 2005. The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Br J Pharmacol 1443: 394-399.
23. Shimokado K, Yokota T, Umezawa K, Sasaguri T, Ogata J. 1994. Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle cells. Arterioscler Thromb 14: 973-981.
24. Squadrito F, Altavilla D, Morabito N, Crisafulli A, D'Anna R, Corrado F, Ruggeri P, Campo GM, Calapai G, Caputi AP, Squadrito G. 2002. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 163: 339-347.
25. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. 2003. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78: 123-130.
26. Verbeuren TJ, Jordaens FH, Van Hove CE, Van Hoydonck AE, Herman AG. 1990. Release and vascular activity of endothelium derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol 191: 173-184
27. Walker HA, Dean TS, Sanders TAB, Jackson G, Ritter GM, Chowienczyk PJ. 2001. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17 β-estradiol. Circulation 103: 258-262.